Patient demographics | Tumor data | Preoperative laboratory values | Postoperative complications | Clavien-Dindo grades | |||||
---|---|---|---|---|---|---|---|---|---|
Variable | n (%) | Variable | n (%) | Variable | x̅ [s] | Variable | n (%) | Variable | n (%) |
Age > 65 | 147 (67.4) | Tumor site | Hb (g/dL) | 12.4 [2.1] | Ileus | 13 (6.0) | No complications | 111 (50.9) | |
Male | 136 (62.4) | Rectum | 49 (22.5) | WBC (× 109/L) | 7.4 [2.2] | Wound infection | 8 (3.7) | CD I | 52 (23.9) |
BMI ≥ 30 | 43 (29.9) | Left colon | 90 (41.3) | Platelets (× 109/L) | 273 [82.6] | Wound dehiscence | 3 (1.4) | CD II | 14 (6.4) |
Patient comorbidity | Right colon | 79 (36.2) | Neutrophils (× 109/L) | 4.8 [1.9] | Hernia | 7 (3.2) | CD III | 12 (5.5) | |
Cardiovascular | 65 (29.8) | Tumor stage T3/T4 | 120 (60.9) | Lymphocytes (× 109/L) | 1.5 [0.6] | Anastomotic leak | 6 (2.8) | CD IV | 27 (12.4) |
Respiratory | 44 (20.2) | Node-positive | 74 (37.6) | PLR | 208 [125.2] | Sepsis | 7 (3.2) | CD V | 2 (0.9) |
Renal | 43 (19.7) | Malignant | 198 (90.8) | NLR | 4.0 [4.5] | Embolism | 8 (3.7) | ||
Diabetes | 34 (15.6) | Moderately/poorly differentiated | 192 (97) | CRP (mg/L) | 18.7 [34.1] | Urinary | 16 (7.3) | ||
Autoimmune | 31 (14.2) | CEA (ng/mL) | 8.4 [24.7] | Renal | 16 (7.3) | ||||
Smoker | 30 (16.3) | Respiratory | 25 (11.5) | ||||||
Laparoscopic | 176 (80.7) | Cardiovascular | 21 (9.6) | ||||||
Neurological | 9 (4.1) |